Boston, MA 03\/21\/2014 (wallstreetpr) – Burlington Stores Inc (NYSE:BURL)<\/b> released its fourth quarter performance Thursday March 20. The retailer of branded clothing, coats and shoes posted strong revenue growth for the quarter but, higher expenses dimmed the bottom line. In the fourth quarter which ended February 1, BURL posted revenue of $1.34 billion, up 1.3 percent from the corresponding quarter a year ago, and in-line with estimate. However, profit fell to $63.6 million from $67.9 million recorded in the same quarter a year ago. Earnings per share in the quarter under review were $1.07, down from $1.15. The trouble in the quarter started with expenses going beyond the anticipated figures. However, the company is looking to adjusted EPS in the range of $1.25 – $1.35 in the current year. Revenue in the current year is expected to go up between 5.8 and 6.8 percent. Analysts on their part are modeling 7 percent revenue growth and $1.38 EPS. And for the current quarter, the management of Burlington Stores Inc (NYSE:BURL) has its eye set on EPS in the range of $0.19 – $0.23, just in-line with projection.<\/p>\n
China Jo Jo Drugstores Inc (NASDAQ:CJJD)<\/b> is headquartered in the People\u2019s Republic of China where it operates 51 store locations. The company distributes mainly pharmaceuticals. Shares of the company were in massive gain in the previous session, going up 17 percent to conclude at $2.34. Thursday session of China Jo Jo Drugstores Inc (NASDAQ:CJJD) came on solid volume whereby almost twice the daily average volume was traded. In the past year, shares traded between $0.47 low and $2.84 high.<\/p>\n
\u00a0ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)<\/b> jumped as much as 11.8 percent after the stock received an encouraging view from Mizuho Financial Group. The stock was initiated with a buy recommendation and price target of $11. Mizuho\u2019s price target implies potential upside of 127 percent from the stock\u2019s closing price on Wednesday. The brokerage observed that ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) stood to benefit from the drugs it was developing. Shares of ZIOP were up 11.75 percent to $5.42 by bell time. Earlier on the shares touched a new one-year high of $5.58.<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 03\/21\/2014 (wallstreetpr) – Burlington Stores Inc (NYSE:BURL) released its fourth quarter performance Thursday March 20. The retailer of branded clothing, coats and shoes […]<\/p>\n","protected":false},"author":32,"featured_media":17708,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[5348,5354,5355,2269,5349,2268],"stock_ticker":[],"class_list":["post-17723","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-burlington-stores-inc-nyseburl","tag-china-jo-jo-drugstores-inc-nasdaqcjjd","tag-nasdaqcjjd","tag-nasdaqziop","tag-nyseburl","tag-ziopharm-oncology-inc-nasdaqziop","entry"],"acf":[],"yoast_head":"\n